Pain

Balancing Opioid Policy and Pain Management

March 2, 2018

Thursday marked the White House Opioid Summit, which welcomed 200 affected Americans to discuss the crisis with Cabinet members.  President Donald Trump declared the opioid abuse epidemic a public health emergency last fall.

Summit on Balanced Pain Management Underscores Need for Access, Coverage

November 17, 2017

“I didn’t like feeling like a victim.  I liked feeling like a warrior.”  So explained Ally Hilfiger – artist, author and daughter of fashion mogul Tommy Hilfiger – who told her story of overcoming Lyme disease at the annual National Summit on Balanced Pain Management.  The summit featured U.S. Representative Tim Ryan (D-Ohio) as well as members of the regulatory community, nonprofits, industry, and patient groups to explore the value of a multi-prong approach to pain treatment.

The Generation that Ends the Opioid Epidemic

October 27, 2017

President Donald Trump declared America’s opioid crisis a public health emergency on Thursday, announcing, “We can be the generation that ends the opioid epidemic.”  But how?

Mind-Body Pain Treatments Pass ICER’s Cost-Effectiveness Test

October 11, 2017

Treating chronic low back pain with approaches such as yoga and talk therapy is cost effective, the Institute for Clinical and Economic Review announced this month.  Will health plans respond by expanding coverage for non-pharmacologic therapies?

Drugs, Data & Opioid Policies

September 19, 2017

America’s drug abuse crisis has reached epic proportions, a recent report from the Centers for Disease Control and Prevention confirms. Drug-related deaths in 2016 alone spiked by 22 percent.

Non-Medical Switching May Increase Health Care Costs, New Study Finds

August 10, 2017

Opting for cheaper prescription drugs seems like an obvious way to cut health care costs.  The assumption has led health plans to employ utilization management techniques with increasing frequency in recent years.  And it’s given rise to a newer phenomenon known as “non-medical switching,” where health plans exclude a drug from coverage or increase patients’ out-of-pocket burden in hopes of persuading patients to take a less expensive drug.